AVITA Medical, Inc. Deferred Tax Assets, in Process Research and Development
AVITA Medical, Inc. (AVHHL) had Deferred Tax Assets, in Process Research and Development of $7.72 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2026-02-12
- 2025-12-31: Deferred Tax Assets, in Process Research and Development $7.72M.
- 2024-12-31: Deferred Tax Assets, in Process Research and Development $7.08M.
- 2023-12-31: Deferred Tax Assets, in Process Research and Development $5.36M.
- 2022-12-31: Deferred Tax Assets, in Process Research and Development $2.21M.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2025-12-31 | $7.72M 10-K · filed 2026-02-12 |
| 2024-12-31 | $7.08M 10-K · filed 2026-02-12 |
| 2023-12-31 | $5.36M 10-K · filed 2025-02-13 |
| 2022-12-31 | $2.21M 10-K · filed 2024-02-22 |